Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Solvimax is a Mexican pharmaceutical company and a key subsidiary of the Neolpharma Group. The company specializes in the development, manufacturing, and commercialization of generic medications, with a strong focus on sterile injectable solutions, oral solids, and electrolyte replacements. Solvimax operates advanced production facilities that comply with international Good Manufacturing Practices (GMP) to ensure the quality and safety of its products. Its extensive portfolio serves both the private market and major public health institutions in Mexico and Latin America. Additionally, the company provides contract manufacturing services (CMO) to international and domestic pharmaceutical partners, leveraging its expertise in sterile fill-finish and lyophilization technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SolviMáx.